hs-cTnI levels were measured in 16 newborns (age at test: 0–5 days) as part of the diagnostic work-up for suspected but not confirmed neonatal infection or metabolic disease, hyperbilirubinemia, prenatal cerebral hemorrhage, or maternal disease (medication, infection, Basedow’s disease). This evidence concerns the gene TNNI3 and Graves disease.